Literature DB >> 3046712

A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin.

K Seroogy1, S Ceccatelli, M Schalling, T Hökfelt, P Frey, J Walsh, G Dockray, J Brown, A Buchan, M Goldstein.   

Abstract

The coexistence of the neuropeptides neurotensin and cholecystokinin and the catecholamine-synthesizing enzyme tyrosine hydroxylase within neurons of the ventral mesencephalon was analyzed using an immunofluorescence triple-labeling technique. Virtually all of the neurotensin-positive cell bodies in the ventral tegmental area, medial substantia nigra pars compacta, retrorubral field, and rostral and caudal linear raphe nuclei were found to contain both cholecystokinin and tyrosine hydroxylase immunoreactivities. The degree of colocalization was lower and more variable in other regions including the ventral and central periaqueductal grey matter and dorsal raphe nucleus. It appeared that immunoreactivities for these 3 neuroactive substances were not contained within the same axonal-like fibers and terminals in the ventral midbrain. These results demonstrate that a subpopulation of dopaminergic neurons, which presumably comprise part of the ascending mesotelencephalic system, contains the two peptides neurotensin and cholecystokinin. Thus, the data suggest a morphological basis for some of the reported functional interactions of these 3 putative neurotransmitters/neuromodulators within this system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046712     DOI: 10.1016/0006-8993(88)90117-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

Review 1.  Dopaminergic neurones: much more than dopamine?

Authors:  Vincent Seutin
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

2.  Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Eur J Neurosci       Date:  2018-02-28       Impact factor: 3.386

Review 3.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

4.  Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment.

Authors:  R Garrett Morgan; Jeffrey T Gibbs; Erica J Melief; Nadia O Postupna; Emily E Sherfield; Angela Wilson; C Dirk Keene; Thomas J Montine; Richard D Palmiter; Martin Darvas
Journal:  Exp Neurol       Date:  2015-06-14       Impact factor: 5.330

5.  Brain expression and song regulation of the cholecystokinin gene in the zebra finch (Taeniopygia guttata).

Authors:  Peter V Lovell; Claudio V Mello
Journal:  J Comp Neurol       Date:  2011-02-01       Impact factor: 3.215

Review 6.  Establishing causality for dopamine in neural function and behavior with optogenetics.

Authors:  Elizabeth E Steinberg; Patricia H Janak
Journal:  Brain Res       Date:  2012-09-29       Impact factor: 3.252

7.  Presence of somatostatin or neurotensin in lateral septal dopaminergic axon terminals of distinct hypothalamic and midbrain origins: convergence on the somatospiny neurons.

Authors:  R L Jakab; C Leranth
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

8.  Neurochemical heterogeneity of the primate nucleus accumbens.

Authors:  K Ikemoto; K Satoh; T Maeda; H C Fibiger
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

Review 9.  The multilingual nature of dopamine neurons.

Authors:  Louis-Eric Trudeau; Thomas S Hnasko; Asa Wallén-Mackenzie; Marisela Morales; Steven Rayport; David Sulzer
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

10.  Effects of dopamine and alpha-2 adrenoreceptor blockade on L-dopa and cholecystokinin-induced gastroprotection.

Authors:  J M Cross; D W Mercer; J Gunter; T A Miller
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.